JP2022031403A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022031403A5 JP2022031403A5 JP2021209374A JP2021209374A JP2022031403A5 JP 2022031403 A5 JP2022031403 A5 JP 2022031403A5 JP 2021209374 A JP2021209374 A JP 2021209374A JP 2021209374 A JP2021209374 A JP 2021209374A JP 2022031403 A5 JP2022031403 A5 JP 2022031403A5
- Authority
- JP
- Japan
- Prior art keywords
- combination according
- antigen
- antibody
- tgfβ1
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023100034A JP2023108057A (ja) | 2016-03-11 | 2023-06-19 | ＴＧＦβ１結合性免疫グロブリンおよびその使用 |
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662307353P | 2016-03-11 | 2016-03-11 | |
| US62/307,353 | 2016-03-11 | ||
| US201762443615P | 2017-01-06 | 2017-01-06 | |
| US62/443,615 | 2017-01-06 | ||
| US201762452866P | 2017-01-31 | 2017-01-31 | |
| US62/452,866 | 2017-01-31 | ||
| PCT/US2017/021972 WO2017156500A1 (en) | 2016-03-11 | 2017-03-10 | Tgfb1-binding immunoglobulins and use thereof |
| JP2018547346A JP2019509737A (ja) | 2016-03-11 | 2017-03-10 | ＴＧＦβ１結合性免疫グロブリンおよびその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018547346A Division JP2019509737A (ja) | 2016-03-11 | 2017-03-10 | ＴＧＦβ１結合性免疫グロブリンおよびその使用 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023100034A Division JP2023108057A (ja) | 2016-03-11 | 2023-06-19 | ＴＧＦβ１結合性免疫グロブリンおよびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022031403A JP2022031403A (ja) | 2022-02-18 |
| JP2022031403A5 true JP2022031403A5 (https=) | 2022-07-06 |
| JP7794630B2 JP7794630B2 (ja) | 2026-01-06 |
Family
ID=58503696
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018547346A Withdrawn JP2019509737A (ja) | 2016-03-11 | 2017-03-10 | ＴＧＦβ１結合性免疫グロブリンおよびその使用 |
| JP2021174552A Withdrawn JP2022028680A (ja) | 2016-03-11 | 2021-10-26 | ＴＧＦβ１結合性免疫グロブリンおよびその使用 |
| JP2021209374A Active JP7794630B2 (ja) | 2016-03-11 | 2021-12-23 | ＴＧＦβ１結合性免疫グロブリンおよびその使用 |
| JP2023100034A Withdrawn JP2023108057A (ja) | 2016-03-11 | 2023-06-19 | ＴＧＦβ１結合性免疫グロブリンおよびその使用 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018547346A Withdrawn JP2019509737A (ja) | 2016-03-11 | 2017-03-10 | ＴＧＦβ１結合性免疫グロブリンおよびその使用 |
| JP2021174552A Withdrawn JP2022028680A (ja) | 2016-03-11 | 2021-10-26 | ＴＧＦβ１結合性免疫グロブリンおよびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023100034A Withdrawn JP2023108057A (ja) | 2016-03-11 | 2023-06-19 | ＴＧＦβ１結合性免疫グロブリンおよびその使用 |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US11643459B2 (https=) |
| EP (2) | EP4169942A1 (https=) |
| JP (4) | JP2019509737A (https=) |
| KR (3) | KR20180122397A (https=) |
| CN (1) | CN109071646A (https=) |
| AU (2) | AU2017230103A1 (https=) |
| BR (1) | BR112018068340A2 (https=) |
| CA (1) | CA3055555A1 (https=) |
| DK (1) | DK3365368T3 (https=) |
| EA (1) | EA201891909A1 (https=) |
| ES (1) | ES2951648T3 (https=) |
| FI (1) | FI3365368T3 (https=) |
| HU (1) | HUE062976T2 (https=) |
| IL (2) | IL307835A (https=) |
| MX (2) | MX2018010948A (https=) |
| PL (1) | PL3365368T3 (https=) |
| PT (1) | PT3365368T (https=) |
| SG (1) | SG11201807176XA (https=) |
| WO (1) | WO2017156500A1 (https=) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3055555A1 (en) | 2016-03-11 | 2017-09-14 | Scholar Rock, Inc. | Tgf.beta.1-binding immunoglobulins and use thereof |
| CN110049773A (zh) * | 2016-07-14 | 2019-07-23 | 供石公司 | TGFβ抗体、方法和用途 |
| BR112019013908A2 (pt) | 2017-01-06 | 2020-02-04 | Scholar Rock, Inc. | inibidores de tgfss1 isoforma-específicos, contexto-permissivos, e seus usos |
| CN110573161A (zh) * | 2017-03-28 | 2019-12-13 | 勃林格殷格翰国际有限公司 | 用于治疗肌营养不良的方法的尼达尼布 |
| PT3621694T (pt) | 2017-05-09 | 2023-10-09 | Scholar Rock Inc | Inibidores de lrrc33 e sua utilização |
| MA49690A (fr) * | 2017-07-28 | 2021-05-19 | Scholar Rock Inc | Inhibiteurs spécifiques du complexe ltbp de tgf-bêta 1 et leurs utilisations |
| EP3694552A1 (en) | 2017-10-10 | 2020-08-19 | Tilos Therapeutics, Inc. | Anti-lap antibodies and uses thereof |
| JP7315566B2 (ja) * | 2018-02-23 | 2023-07-26 | 中外製薬株式会社 | 種交差性抗潜在型ＴＧＦ－β１抗体および使用方法 |
| MA53125A (fr) | 2018-07-11 | 2021-05-19 | Scholar Rock Inc | Inhibiteurs de tgf?1 sélectifs selon l'isoforme à affinité élevée |
| US20210340238A1 (en) | 2018-07-11 | 2021-11-04 | Scholar Rock, Inc. | TGFß1 INHIBITORS AND USE THEREOF |
| SI3677278T1 (sl) | 2018-07-11 | 2022-01-31 | Scholar Rock, Inc. | Izoformno selektivni zaviralci TGFBETA1 in uporaba le-teh |
| CN113164780A (zh) | 2018-10-10 | 2021-07-23 | 泰洛斯治疗公司 | 抗lap抗体变体及其用途 |
| CN113613725B (zh) * | 2018-11-05 | 2025-09-23 | 路德维格癌症研究所有限公司 | 人源化和变体TGF-β1特异性抗体及其方法和用途 |
| CN113677711B (zh) | 2019-01-30 | 2025-05-30 | 供石公司 | TGFβ的LTBP复合特异性抑制剂及其用途 |
| BR112021024820A2 (pt) * | 2019-06-10 | 2022-01-25 | Shandong Boan Biotechnology Co Ltd | Proteína de fusão bifuncional contra pdl1 e tgfss e uso da mesma |
| CN114729370B (zh) * | 2019-08-28 | 2025-03-21 | 中外制药株式会社 | 跨物种抗潜伏TGF-β1抗体和使用方法 |
| TW202135862A (zh) * | 2020-01-11 | 2021-10-01 | 美商供石公司 | TGFβ抑制劑及其用途 |
| CA3166328A1 (en) * | 2020-01-11 | 2021-07-15 | Scholar Rock, Inc. | Tgf-beta inhibitors and use thereof |
| WO2021195098A1 (en) * | 2020-03-24 | 2021-09-30 | Bio-Techne Corporation | Methods of using a tgf beta knockout cell line and compositions resulting therefrom |
| BR112023014319A2 (pt) * | 2021-01-18 | 2023-09-26 | Jiangxi Jemincare Group Co Ltd | Anticorpo contra a proteína garp e aplicação do mesmo |
| JP7280400B2 (ja) * | 2021-02-26 | 2023-05-23 | 中外製薬株式会社 | 種交差性抗潜在型ＴＧＦ－β１抗体の使用 |
| WO2022180764A1 (en) | 2021-02-26 | 2022-09-01 | Chugai Seiyaku Kabushiki Kaisha | Uses of cross-species anti-latent tgf-beta 1 antibodies |
| WO2022204581A2 (en) | 2021-03-26 | 2022-09-29 | Scholar Rock, Inc. | Tgf-beta inhibitors and use thereof |
| WO2022206753A1 (zh) * | 2021-03-29 | 2022-10-06 | 山东先声生物制药有限公司 | GARP/TGFβ1抗体及其应用 |
| EP4348260A2 (en) | 2021-06-03 | 2024-04-10 | Scholar Rock, Inc. | Tgf-beta inhibitors and therapeutic use thereof |
| EP4370148A1 (en) | 2021-07-14 | 2024-05-22 | Scholar Rock, Inc. | Ltbp complex-specific inhibitors of tgf beta1 and uses thereof |
| EP4499680A1 (en) | 2022-03-29 | 2025-02-05 | Allogene Therapeutics, Inc. | Chimeric switch receptors for the conversion of immunesuppressive signals to costimulatory signals |
| WO2024023283A1 (en) | 2022-07-29 | 2024-02-01 | Institut National de la Santé et de la Recherche Médicale | Lrrc33 as a biomarker and biotarget in cutaneous t-cell lymphomas |
| GB202219154D0 (en) * | 2022-12-19 | 2023-02-01 | Metacurum Biotech Ab | Antibodies and uses thereof |
| TW202434643A (zh) * | 2023-01-09 | 2024-09-01 | 大陸商北京拓界生物醫藥科技有限公司 | ＴＧＦβ１結合分子、ＧＡＲＰ－ＴＧＦβ１結合分子及其醫藥用途 |
| IL322242A (en) | 2023-02-10 | 2025-09-01 | Chugai Pharmaceutical Co Ltd | Anti-latent TGF-BETA 1 antibodies and methods of use |
| WO2024187051A1 (en) | 2023-03-07 | 2024-09-12 | Scholar Rock, Inc. | Tgf-beta inhibitors for use for treating resistant or unresponsive cancer in patients |
| WO2025240343A1 (en) | 2024-05-13 | 2025-11-20 | Scholar Rock, Inc. | Tgf-beta inhibitors for treating cancer |
| CN120131938B (zh) * | 2025-03-19 | 2025-12-23 | 广州奥奇生物技术有限公司 | 一种益生菌制剂的制备方法及其在改善睡眠中的应用 |
Family Cites Families (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
| JPS6147500A (ja) | 1984-08-15 | 1986-03-07 | Res Dev Corp Of Japan | キメラモノクロ−ナル抗体及びその製造法 |
| EP0173494A3 (en) | 1984-08-27 | 1987-11-25 | The Board Of Trustees Of The Leland Stanford Junior University | Chimeric receptors by dna splicing and expression |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| US5262319A (en) | 1985-04-19 | 1993-11-16 | Oncogene Science, Inc. | Method for obtaining bone marrow free of tumor cells using transforming growth factor β3 |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| EP0436597B1 (en) | 1988-09-02 | 1997-04-02 | Protein Engineering Corporation | Generation and selection of recombinant varied binding proteins |
| US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| DK0585287T3 (da) | 1990-07-10 | 2000-04-17 | Cambridge Antibody Tech | Fremgangsmåde til fremstilling af specifikke bindingsparelementer |
| CA2095633C (en) | 1990-12-03 | 2003-02-04 | Lisa J. Garrard | Enrichment method for variant proteins with altered binding properties |
| EP1820858B1 (en) | 1991-03-01 | 2009-08-12 | Dyax Corporation | Chimeric protein comprising micro-protein having two or more disulfide bonds and embodiments thereof |
| ATE414768T1 (de) | 1991-04-10 | 2008-12-15 | Scripps Research Inst | Bibliotheken heterodimerer rezeptoren mittels phagemiden |
| DE4122599C2 (de) | 1991-07-08 | 1993-11-11 | Deutsches Krebsforsch | Phagemid zum Screenen von Antikörpern |
| US5786464C1 (en) | 1994-09-19 | 2012-04-24 | Gen Hospital Corp | Overexpression of mammalian and viral proteins |
| GB9601081D0 (en) * | 1995-10-06 | 1996-03-20 | Cambridge Antibody Tech | Specific binding members for human transforming growth factor beta;materials and methods |
| NZ331688A (en) | 1996-03-28 | 2000-02-28 | Univ Johns Hopkins | Soluble divalent and multivalent heterodimeric analogs of proteins |
| US6114148C1 (en) | 1996-09-20 | 2012-05-01 | Gen Hospital Corp | High level expression of proteins |
| US6914128B1 (en) | 1999-03-25 | 2005-07-05 | Abbott Gmbh & Co. Kg | Human antibodies that bind human IL-12 and methods for producing |
| US6492497B1 (en) | 1999-04-30 | 2002-12-10 | Cambridge Antibody Technology Limited | Specific binding members for TGFbeta1 |
| KR100919593B1 (ko) | 2000-06-29 | 2009-09-29 | 아보트 러보러터리즈 | 이중 특이성 항체 및 이의 제조 방법 및 이를 포함하는 조성물 |
| GB0230202D0 (en) | 2002-12-27 | 2003-02-05 | Domantis Ltd | Ligand |
| US7803553B2 (en) * | 2003-09-04 | 2010-09-28 | Riken | Methods of use of antibodies which recognize a protease cleavage site of an LAP fragment of TGF-β |
| AR045563A1 (es) | 2003-09-10 | 2005-11-02 | Warner Lambert Co | Anticuerpos dirigidos a m-csf |
| TR201901929T4 (tr) | 2005-02-08 | 2019-03-21 | Genzyme Corp | TGFBeta'ya antikorlar. |
| BRPI0608376A8 (pt) | 2005-04-22 | 2018-10-16 | Lilly Co Eli | composição de ligação, método de uso de uma composição de ligação, e, kit de detecção |
| ME00832B (me) | 2007-03-22 | 2012-03-20 | Ucb Biopharma Sprl | Vezivni proteini uključujući antitjela, derivate antitjela i fragmente antitjela, koji specifično vezuju cd154 i njihova upotreba |
| PE20091163A1 (es) | 2007-11-01 | 2009-08-09 | Wyeth Corp | Anticuerpos para gdf8 |
| US20100260668A1 (en) | 2008-04-29 | 2010-10-14 | Abbott Laboratories | Dual Variable Domain Immunoglobulins and Uses Thereof |
| TW201006485A (en) | 2008-06-03 | 2010-02-16 | Abbott Lab | Dual variable domain immunoglobulins and uses thereof |
| JO3096B1 (ar) | 2008-11-07 | 2017-03-15 | Imclone Llc | الأجسام المضادة لمستقبل ii مضاد tgfb |
| WO2011102483A1 (ja) * | 2010-02-19 | 2011-08-25 | 独立行政法人理化学研究所 | ヒトTGF-βのLAPに結合する抗体 |
| AR081556A1 (es) | 2010-06-03 | 2012-10-03 | Glaxo Group Ltd | Proteinas de union al antigeno humanizadas |
| MX341578B (es) | 2011-02-08 | 2016-08-25 | Abbvie Inc | Tratamiento de la osteoartritis y del dolor. |
| ES2765874T3 (es) | 2011-05-25 | 2020-06-11 | Innate Pharma Sa | Anticuerpos anti-KIR para el tratamiento de trastornos inflamatorios |
| CN103732623B (zh) | 2011-06-03 | 2017-09-29 | 佐马技术有限公司 | 对TGF‑β具有特异性的抗体 |
| RU2014100111A (ru) | 2011-06-10 | 2015-07-20 | МЕДИММЬЮН, ЭлЭлСи | МОЛЕКУЛЫ, СВЯЗЫВАЮЩИЕСЯ С Psl Pseudomonas, И ПУТИ ИХ ПРИМЕНЕНИЯ |
| WO2013054307A2 (en) | 2011-10-14 | 2013-04-18 | Novartis Ag | Antibodies and methods for wnt pathway-related diseases |
| WO2013068902A1 (en) | 2011-11-08 | 2013-05-16 | Pfizer Inc. | Methods of treating inflammatory disorders using anti-m-csf antibodies |
| DK2780368T3 (en) | 2011-11-14 | 2018-02-05 | Regeneron Pharma | COMPOSITIONS AND PROCEDURES FOR INCREASING MUSCLE MASS AND MUSCLE STRENGTH BY SPECIFIC ANTAGONIZATION OF GDF8 AND / OR ACTIVIN A |
| US9518112B2 (en) | 2012-03-08 | 2016-12-13 | Ludwig Institute For Cancer Research Ltd | TGF-β1 specific antibodies and methods and uses thereof |
| JP2016500704A (ja) | 2012-11-06 | 2016-01-14 | スカラー ロック インコーポレイテッドＳｃｈｏｌａｒ Ｒｏｃｋ，Ｉｎｃ． | 細胞シグナル伝達を変調するための組成物及び方法 |
| EP2968548B1 (en) | 2013-03-15 | 2020-09-09 | Beth Israel Deaconess Medical Center, Inc. | Methods and compositions for the generation and use of conformation-specific antibodies |
| RS61778B1 (sr) | 2013-05-06 | 2021-06-30 | Scholar Rock Inc | Kompozicije i postupci za modulaciju faktora rasta |
| EP2832747A1 (en) * | 2013-08-01 | 2015-02-04 | Université Catholique de Louvain | Anti-GARP protein and uses thereof |
| ES2860952T3 (es) | 2013-08-01 | 2021-10-05 | Univ Catholique Louvain | Proteína anti-garp y usos de la misma |
| EP3139957A4 (en) | 2014-05-06 | 2018-04-25 | Scholar Rock, Inc. | Compositions and methods for growth factor modulation |
| NZ726168A (en) | 2014-06-26 | 2022-05-27 | Heidelberg Immunotherapeutics Gmbh | Topical application for an anti-hsv antibody |
| BR112017009931A2 (pt) | 2014-11-18 | 2018-02-14 | Pasteur Institut | anticorpos policlonais, agente de diagnóstico, método de detecção de sorogrupo x de neisseria meningitidis in vitro, método in vitro de diagnóstico de infecção no sorogrupo x de neisseria meningitidis, kit e teste de diagnóstico, uso do kit de diagnóstico e método de produção de anticorpos policlonais |
| WO2016115345A1 (en) | 2015-01-14 | 2016-07-21 | The Brigham And Women's Hospital, | Treatment of cancer with anti-lap monoclonal antibodies |
| TWI733661B (zh) | 2015-03-04 | 2021-07-21 | 美商健臻公司 | 以高親合性、結合性及特異性結合轉化生長因子－β１的經修飾ＩｇＧ抗體 |
| CA3055555A1 (en) | 2016-03-11 | 2017-09-14 | Scholar Rock, Inc. | Tgf.beta.1-binding immunoglobulins and use thereof |
| CN110049773A (zh) | 2016-07-14 | 2019-07-23 | 供石公司 | TGFβ抗体、方法和用途 |
| BR112019013908A2 (pt) | 2017-01-06 | 2020-02-04 | Scholar Rock, Inc. | inibidores de tgfss1 isoforma-específicos, contexto-permissivos, e seus usos |
| EP3694552A1 (en) | 2017-10-10 | 2020-08-19 | Tilos Therapeutics, Inc. | Anti-lap antibodies and uses thereof |
| CN113164780A (zh) | 2018-10-10 | 2021-07-23 | 泰洛斯治疗公司 | 抗lap抗体变体及其用途 |
-
2017
- 2017-03-10 CA CA3055555A patent/CA3055555A1/en active Pending
- 2017-03-10 KR KR1020187028835A patent/KR20180122397A/ko not_active Ceased
- 2017-03-10 EA EA201891909A patent/EA201891909A1/ru unknown
- 2017-03-10 EP EP22195559.4A patent/EP4169942A1/en active Pending
- 2017-03-10 AU AU2017230103A patent/AU2017230103A1/en not_active Abandoned
- 2017-03-10 BR BR112018068340A patent/BR112018068340A2/pt active Search and Examination
- 2017-03-10 IL IL307835A patent/IL307835A/en unknown
- 2017-03-10 MX MX2018010948A patent/MX2018010948A/es unknown
- 2017-03-10 PL PL17716332.6T patent/PL3365368T3/pl unknown
- 2017-03-10 DK DK17716332.6T patent/DK3365368T3/da active
- 2017-03-10 KR KR1020257001174A patent/KR20250011248A/ko active Pending
- 2017-03-10 EP EP17716332.6A patent/EP3365368B1/en active Active
- 2017-03-10 WO PCT/US2017/021972 patent/WO2017156500A1/en not_active Ceased
- 2017-03-10 US US16/083,637 patent/US11643459B2/en active Active
- 2017-03-10 KR KR1020237018780A patent/KR20230088508A/ko not_active Ceased
- 2017-03-10 PT PT177163326T patent/PT3365368T/pt unknown
- 2017-03-10 CN CN201780023887.8A patent/CN109071646A/zh active Pending
- 2017-03-10 SG SG11201807176XA patent/SG11201807176XA/en unknown
- 2017-03-10 JP JP2018547346A patent/JP2019509737A/ja not_active Withdrawn
- 2017-03-10 ES ES17716332T patent/ES2951648T3/es active Active
- 2017-03-10 HU HUE17716332A patent/HUE062976T2/hu unknown
- 2017-03-10 FI FIEP17716332.6T patent/FI3365368T3/fi active
-
2018
- 2018-08-29 IL IL261442A patent/IL261442A/en unknown
- 2018-09-10 MX MX2024005811A patent/MX2024005811A/es unknown
-
2021
- 2021-10-26 JP JP2021174552A patent/JP2022028680A/ja not_active Withdrawn
- 2021-12-23 JP JP2021209374A patent/JP7794630B2/ja active Active
-
2023
- 2023-03-31 US US18/193,979 patent/US20230348583A1/en active Pending
- 2023-06-19 JP JP2023100034A patent/JP2023108057A/ja not_active Withdrawn
-
2024
- 2024-04-24 AU AU2024202692A patent/AU2024202692A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022031403A5 (https=) | ||
| JP2019509737A5 (https=) | ||
| FI3365368T3 (fi) | Tgf-beeta-1:tä sitovia immunoglobuliineja ja niiden käyttö | |
| JP2022188083A5 (https=) | ||
| JP2017039771A5 (https=) | ||
| CN107148285A (zh) | 吡咯并苯并二氮杂*‑抗体缀合物 | |
| JP2021534158A5 (https=) | ||
| RU2010142390A (ru) | Комбинации конъюгата анти-her2-антитело-лекарственное средство и химиотерапевтических средств и способы применения | |
| JP2015511609A5 (https=) | ||
| JP2019529476A5 (https=) | ||
| JP2022506829A5 (https=) | ||
| JP2022537269A5 (https=) | ||
| JP2015517523A5 (https=) | ||
| CN109069469A (zh) | 治疗癌症的方法 | |
| Frankenthaler et al. | Fibrosarcoma of the head and neck | |
| JP2021105005A5 (https=) | ||
| JP2024542633A5 (https=) | ||
| JP2022502399A5 (https=) | ||
| Vaisitti et al. | Vls-101 is a novel therapeutic antibody-drug conjugate (ADC) targeting receptor tyrosine kinase-like orphan receptor 1 (ROR1) in Richter's syndrome (RS) | |
| Glaser et al. | Complications of intracavitary brachytherapy for gynecologic cancers and their management: a comprehensive review | |
| RU2004121162A (ru) | Применение анастрозола для лечения женщин в постклимактерическом периоде, которые страдают ранним раком молочной железы | |
| Freiberger et al. | Quality of life up to 10 years after external beam radiotherapy and/or brachytherapy for prostate cancer | |
| MX2022002555A (es) | Conjugados de farmaco de anticuerpo de union a receptor de tipo ii de la hormona anti-mulleriana humana (amhrii) y uso de los mismos en el tratamiento de canceres. | |
| JP2020521786A5 (https=) | ||
| CN110545803A (zh) | 用于淋巴结阳性、早期、激素受体阳性、人表皮生长因子受体2阴性乳腺癌的辅助治疗的内分泌疗法和abemaciclib组合 |